The United States Natriuretic Peptide Market represents the largest share of the North American region, supported by the country's high burden of cardiovascular disorders and strong focus on preventive healthcare. Increasing utilization of BNP and NT-proBNP tests for the diagnosis, prognosis, and monitoring of heart failure is contributing to sustained market growth. The presence of leading...